Agmatine, an endogenous ligand, interacts both with the alpha(2)-adrenocept
ors and with the imidazoline binding sites. The effect of intrathecally adm
inistered agmatine on carrageenan-induced thermal hyperalgesia was investig
ated by means of a paw-withdrawal test in rats. The effect of agmatine on m
orphine-induced anti-hyperalgesia was also studied. Intrathecal agmatine in
doses larger than 250 mu g caused a decrease in the pain threshold, with v
ocalization and agitation lasting for several hours in all animals. Agmatin
e alone at 1-100 mu g did not give rise to any change in the thermal withdr
awal threshold in the contralateral non-inflamed paw. Agmatine pretreatment
was found to dose-dependently attenuate the thermal hyperalgesia induced b
y intraplantar carrageenan. The effect of 100 mu g agmatine was completely
lost by 60 min, whereas the effect of 50 mu g was of similar magnitude but
exhibited a longer duration. Agmatine posttreatment had a slighter effect.
Agmatine pretreatment (100 mu g) together with 1 mu g morphine (subeffectiv
e dose) has significantly higher anti-hyperalgesic effect then the individu
al compounds by themselves. These are the first data demonstrating the beha
vioral and anti-hyperalgesic effects of intrathecal agmatine. The results r
eveal important interactions between intrathecal agmatine and opioids in th
ermal hyperalgesia. (C) 1999 Elsevier Science B.V. All rights reserved.